" /> Human papilloma virus 16 & 18 45 E6 E7 mRNA:PrThr:Pt:Cvx:Ord:Probe.amp - CISMeF





Preferred Label : Human papilloma virus 16 & 18 45 E6 E7 mRNA:PrThr:Pt:Cvx:Ord:Probe.amp;

LOINC status : DEPRECATED;

LOINC display name : HPV 16 and 18 45 E6 E7 mRNA Probe amp Ql (Cvx);

LOINC long common name : Deprecated Human papilloma virus 16 and 18 45 E6 E7 mRNA [Presence] in Cervix by Probe with amplification;

LOINC short name : Deprecated HPV16 18 45 E6 E7mRNA Cervix;

LOINC description : Detects E6/E7 viral messenger RNA (mRNA) of human papillomavirus (HPV) types 16, 18, and 45 in cervical specimens from women with positive HPV assay results. For women 21-years and older with atypical squamous cells of undetermined significance (ASC-US) cervical cytology results, and HPV positive assay results, this assay can be used to assess the presence or absence of high-risk HPV genotypes 16, 18, and/or 45. For women 30-years and older, the HPV 16, 18, and/or 45 genotype assay can be used to test samples from women with HPV assay positive results, along with cervical cytology results. This assay has not been evaluated for HPV vaccinated patients or in cases of suspected abuse. It differentiates HPV 16 from HPV 18 and/or HPV 45, but does not differentiate HPV 18 and HPV 45. This term was created for, but not limited in use to, the Aptima HPV 16 18/45 genotype assay which uses target capture, target amplification by transcription-mediated amplification and detection of the amplification products by hybridization protection.;

Obsolete resource : true;

Details


You can consult :


Nous contacter.
08/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.